Calculated treatment
Open Access
- 17 July 2013
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 499 (7458) , 291-292
Abstract
Mathematical modelling linked with patient data suggests that combination therapy is more effective than sequential treatment at preventing drug resistance in cancer. This predictive approach may pave the way for personalized therapies.Keywords
This publication has 8 references indexed in Scilit:
- Evolutionary dynamics of cancer in response to targeted combination therapyeLife, 2013
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Optimizing Combination Therapies with Existing and Future CML DrugsPLOS ONE, 2010
- The Worst Drug Rule Revisited: Mathematical Modeling of Cyclic Cancer TreatmentsBulletin of Mathematical Biology, 2010
- Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid LeukemiaPLOS ONE, 2009
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinationsBlood, 2006
- Drug resistance in cancer: Principles of emergence and preventionProceedings of the National Academy of Sciences, 2005